Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The U.S. demands Gavi eliminate thimerosal from vaccines for future funding, despite scientific consensus on its safety.

flag The U.S. government has told Gavi it must phase out thimerosal, a mercury-based vaccine preservative, to receive future funding, citing safety concerns despite scientific consensus that it is safe. flag The condition applies to both pending and future U.S. contributions, following a prior $300 million funding cut. flag Gavi, which supports immunization in low-income countries, says any changes require scientific approval and board consent. flag Thimerosal remains in use in multi-dose vials due to cost and distribution advantages, especially in developing nations. flag The move reflects broader U.S. efforts to shape global health policy under the 'America First' agenda, amid cuts to international health programs and the withdrawal from the WHO.

9 Articles